MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SLNCF made $559K in revenue. -$88,612K in net income. Net profit margin of -15851.88%.

Income Overview

Revenue
$559K
Net Income
-$88,612K
Net Profit Margin
-15851.88%
EPS
-$0.63
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Revenue
559
Cost of sales
215
Gross profit
344
Research and development costs
67,753
General and administrative expenses
22,344
Restructuring charges
1,324
Operating loss
-91,077
Foreign currency (loss)/gain, net
-8,467
Other income, net
3,480
Benefit from r&d credit
7,463
Loss before income tax expense
-88,601
Income tax expense
11
Net loss
-88,612
Basic EPS
-0.63
Diluted EPS
-0.63
Basic Average Shares
141,694,702
Diluted Average Shares
141,694,702
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$88,612K Loss before incometax expense-$88,601K Income tax expense$11K Benefit from r&d credit$7,463K Revenue$559K Other income, net$3,480K Operating loss-$91,077K Gross profit$344K Foreign currency(loss)/gain, net-$8,467K Cost of sales$215K Research and developmentcosts$67,753K General andadministrative expenses$22,344K Restructuring charges$1,324K

Silence Therapeutics plc (SLNCF)

Silence Therapeutics plc (SLNCF)